SLNO Q1 2020 Earnings — Soleno Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SLNOSoleno Therapeutics, Inc.

$2B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

$9M

Net Income

-$6M

EPS (Diluted)

$-1.95

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$392,000

Balance Sheet

Total Assets

$32M

Total Liabilities

$23M

Stockholders' Equity

$9M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	$9M	-$5M	+286.5%
Net Income	-$6M	-$7M	+16.7%